Indo Borax & Chemicals: Open Offer for 26% Stake at ₹256.30 per Share
Zenrock Chemicals Private Limited, along with its associates, is making an open offer to acquire up to 26.00% of Indo Borax & Chemicals Limited's voting share capital at ₹256.30 per share. The offer aims to purchase 83,43,400 equity shares. The tendering period is scheduled from February 6 to February 19, 2026.
An open offer for a significant stake (26%) at a specific price can impact the company's shareholding structure and market perception, warranting a medium impact assessment.
The announcement is a procedural update regarding an open offer, providing details of the terms and schedule. It does not inherently contain positive or negative news about the company's performance or future outlook.
Indo Borax & Chemicals Limited has received a Draft Letter of Offer (DLOF) dated December 30, 2025, in connection with an open offer to its public shareholders. The offer is being made by Zenrock Chemicals Private Limited, along with India Special Assets Fund III, ISAF III Onshore Fund, and Special Situation India Fund (collectively referred to as PACs).
The open offer aims to acquire up to 83,43,400 equity shares, representing 26.00% of the voting share capital, at a price of ₹256.30 per share, payable in cash. This offer is being made pursuant to SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
The tentative schedule of activities indicates that the Public Announcement for the open offer is expected on February 5, 2026, with the tendering period commencing on February 6, 2026, and closing on February 19, 2026. The final dispatch of the Letter of Offer to shareholders is scheduled for January 30, 2026.
What to do with a filing like this
Indo Borax & Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under substantial acquisition of shares and takeovers. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Indo Borax & Chemicals Limited. Read the original for the full detail.